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Abstract
Obesity due to excessive food intake and the lack of 
physical activity is becoming one of the most serious 
public health problems of the 21st century. With the 
increasing prevalence of obesity, non-alcoholic fatty 
liver disease is also emerging as a pandemic. While 
previously this pathophysiological condition was mainly 
attributed to triglyceride accumulation in hepatocytes, 
recent data show that the development of oxidative 
stress, lipid peroxidation, cell death, inflammation and 
fibrosis are mostly due to accumulation of fatty acids, 
and the altered composition of membrane phospholi-
pids. In fact, triglyceride accumulation might play a 
protective role, and the higher toxicity of saturated or 
trans fatty acids seems to be the consequence of a 
blockade in triglyceride synthesis. Increased membrane 
saturation can profoundly disturb cellular homeosta-
sis by impairing the function of membrane receptors, 
channels and transporters. However, it also induces 
endoplasmic reticulum stress via  novel sensing mecha-
nisms of the organelle’s stress receptors. The triggered 
signaling pathways in turn largely contribute to the 
development of insulin resistance and apoptosis. The-
se findings have substantiated the lipotoxic liver injury 
hypothesis for the pathomechanism of hepatosteatosis. 
This minireview focuses on the metabolic and redox 
aspects of lipotoxicity and lipoapoptosis, with special 
regards on the involvement of endoplasmic reticulum 
stress responses.
© 2013 Baishideng. All rights reserved.
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Core tip: Surplus of free fatty acids contributes to hepatic 
injuries in obesity and type 2 diabetes. Intracellular ac-
cumulation of fatty acyl-CoA causes oxidative and endo-
plasmic reticulum (ER) stress, which lead to cell death, 
inflammation and fibrosis. Steatohepatosis is the conse-
quence of an intensive fat synthesis, aiming to reduce 
the metabolic burden. The higher toxicity of saturated vs  
unsaturated fatty acids is partly due to a limited capacity 
of the liver cells to insert them into triglycerides. More-
over, increased membrane saturation triggers the ER 
stress response though a unique mechanism, which ag-
gravates the metabolic derangements and liver injuries.
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INTRODUCTION
Special metabolic features make hepatocytes play a cen-
tral role in the metabolism of  nutrients as well as endo- 
and xenobiotics. Liver can consume or produce various 
nutrients with a great compliance and adapts quickly to 
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changing circumstances. However, the challenge raised 
by substantial alterations in modern life style and diet or 
the abuse of  certain foods or drinks pushes the limits 
of  adjustability, which leads to liver damage and meta-
bolic disorders. The increasing prevalence of  obesity, 
the metabolic syndrome and type 2 diabetes brings the 
pathological role of  fatty acids into the focus of  interest. 
This review is focused on the metabolic and redox bases 
of  the fatty acid-induced cell injuries (lipotoxicity) and 
cell death (lipoapoptosis) in hepatocytes, with special re-
gards to the contribution of  oxidative and endoplasmic 
reticulum (ER) stress.
FATTY ACID METABOLISM IN THE LIVER
Liver plays a prominent role in maintaining a balanced 
nutrient supply in blood throughout the ever changing 
nutritional and metabolic conditions. Therefore, hepato-
cytes can shift from intensive fatty acid synthesis (in fed 
state) to rapid fatty acid breakdown (in starvation). Fatty 
acids, the most efficiently and economically storable 
fuel molecules are synthesized from the excess of  car-
bohydrates and amino acids during the absorptive phase 
(Figure 1A). However, they are not released into the 
blood plasma as non-esterified or free fatty acids (NEFA 
or FFA) but incorporated into complex lipids such as 
triglycerides, phosphoglycerolipids or cholesterylesters 
in the ER membrane[1]. Microsomal triglyceride transfer 
protein (MTP) mediates the association of  triglycerides 
with ApoB100 in the ER lumen and the assembled very 
low density lipoprotein (VLDL) lipoprotein particles 
finally leave the cell through exocytosis[2] (Figure 1A). 
Fatty acid components of  ingested lipids are absorbed 
predominantly as reconstructed complex lipids packed in 
chylomicrons. These lipoproteins reach the systemic cir-
culation through lymph vessels rather than portal veins 
and deliver triglycerides in the adipose tissue for storage.
FFAs normally derive from triglyceride breakdown 
in the adipocytes, and hence their abundance occurs 
in starvation when store mobilization is stimulated by 
hormones (e.g., glucagon, adrenalin and glucocorti-
coids)[3]. FFAs are utilized as energy source in the liver 
cells. After a protein-mediated uptake across the plasma 
membrane[4], they are activated to acyl-CoA, transported 
into the mitochondrial matrix via carnitine shuttle and 
catabolized through β-oxidation and citrate cycle[5]. Long 
term starvation can deprive citrate cycle of  intermedi-
ates and make it unable to keep pace with acetyl-CoA 
production. Accumulating acetyl-CoA is diverted to-
ward the synthesis of  β-ketobutyrate (acetoacetate) and 
β-hydroxybutyrate[3]. These ketone bodies are secreted 
from the hepatocytes into the blood plasma and serve 
as alternative fuels to most aerobic tissues including the 
brain (Figure 1B).
Fatty acids, either endogenous or exogenous, are han-
dled in an activated form, i.e., attached to CoA through a 
thioester bond. Carnitine shuttle leading to degradation 
as well as acyl transferase enzymes incorporating fatty ac-
ids in complex lipids require the formation acyl-CoA in 
the cytosolic compartment[6]. Fatty acyl-CoA molecules 
can also be modified by ER-associated enzymes to reach 
the species-specific composition of  triglycerides and 
phospholipids. These modifications include chain elon-
gation and desaturation (Figure 1A). Monounsaturated 
fatty acids typically contain a cis double bond at the Δ9 
position, which is inserted into fatty acyl-CoAs by stea-
ryl-CoA desaturase 1 (SCD1) in humans. SCD1 converts 
palmitoyl (C16:0)-CoA into palmitoleoyl (C16:1)-CoA and 
stearoyl (C18:0)-CoA to oleoyl (C18:1)-CoA. It is an iron-
containing enzyme that receives electrons from NAD(P)H 
through cytochrome b5 reductase and cytochrome b5 in 
the ER membrane[7]. Ncb5or, a novel soluble oxidore-
ductase contains both cytochrome b5 reductase like and 
cytochrome b5 like domains and hence it is also proposed 
551 October 27, 2013|Volume 5|Issue 10|WJH|www.wjgnet.com
 
In starved state
Activation by
acyl-CoA synthase
FAs
Hepatocyte
Saturated and 
unsaturated 
fatty acids
(FFAS)
FA-CoAs
Ketone
bodies
ROS
Oxidative
phosphorylation
Elec
tron
s
Electrons
β-Oxidation Mitochondria
Acetyl-CoA Ketone
bodies
Citrate cycle
CO2
ATP
Catabolism
In fed state
Amino acids
Acetyl-CoA
Monosaccharides
and amino acids
Hepatocyte
Monosaccharides
Saturated
fatty acyl-CoAs
(SFA-CoAs)
Synthesis
Desaturases
e.g., SCD1
Unsaturated
fatty acyl-CoAs
(UFA-CoAs)
TriglyceridesPhospholipids
VLDL
A
B
Figure 1  Fatty acid metabolism in the liver. A: In fed state, monosaccharides 
and amino acids are taken up from the portal blood and converted to fatty acyl-
CoAs through acetyl-CoA intermediate; The primary endogenous fatty acids 
(e.g., palmitate) are saturated. Formation of mono- or polyunsaturated fatty 
acids involves modification(s) by desaturase enzymes; Newly synthesized fatty 
acids are inserted into complex (saponifiable) lipids, which in turn are packed in 
very low density lipoprotein (VLDL) particles and so secreted from the hepato-
cytes; B: In starvation, free fatty acids (FFAs) derive from triglyceride mobiliza-
tion in the adipose tissue. After a protein-mediated uptake across the plasma 
membrane, they are activated to acyl-CoA, and catabolized in the mitochondria 
through β-oxidation and citrate cycle. These metabolic pathways provide elec-
trons to oxidative phosphorylation, the major source of ATP and ROS in aerobic 
cells. Shortage of citrate cycle intermediates leads to accumulation of acetyl-
CoA, and thence enhances the synthesis of ketone bodies.
to participate in fatty acid desaturation[8]. 
Membrane lipid saturation is regulated through the 
activity of  various lysophospolipid acyltransferase en-
zymes exhibiting different acyl-CoA specificities. For ex-
ample, among the enzymes involved in phosphatidylcho-
line remodeling, lysophosphatidylcholine acyltransferase 
1 (LPCAT1) preferentially incorporates saturated fatty 
acids (e.g., palmitate)[9] while LPCAT3 favors polyunsatu-
rated fatty acids (e.g., arachidonic acid)[10], which allows 
modulation of  phospholipid fatty acid composition 
through altered expression of  these isoenzymes[11]. 
HEPATOSTEATOSIS
Triglyceride deposition within the hepatocytes is the 
hallmark of  both alcoholic and nonalcoholic fatty liver 
diseases (AFLD and NAFLD)[12]. It occurs when VLDL 
assembly and secretion cannot keep pace with lipid 
synthesis. This hepatosteatosis can be caused by various 
conditions including stimulated hepatic fatty acid syn-
thesis due to overfeeding and high fructose consump-
tion[13] and inhibition of  MTP[14,15]. Ethanol, one of  the 
best known inducers of  fatty liver both enhances fatty 
acid synthesis and hinders VLDL secretion[16]. It has 
been revealed that elevated FFA level should also be 
considered as a major cause of  hepatosteatosis. Combi-
nation of  genetic predisposition with certain environ-
mental factors, such as sedentary life style, overfeeding 
and obesity can lead to a surplus of  FFA due to deregu-
lation of  fatty acid storage and mobilization. The meta-
bolic stress caused by excessive supply of  nutrients in 
various tissues comprises oxidative and organelle stress 
components. The consequent stress response and in-
flammatory reaction can lead to insulin resistance, which 
favors triglyceride mobilization and decreases FFA 
uptake in the adipocytes[17]. Untrained skeletal muscle 
of  low metabolic rate and of  small relative mass has a 
limited contribution to fuel consumption, which further 
increases both insulin resistance and the strain on the 
adipose tissue. Moreover, the increased adipocyte mass 
is associated with an elevated FFA release. Enlargement 
of  visceral adipose tissue is especially important because 
it secretes FFA into the portal circulation, i.e., directly 
to the liver. In addition to the mounting FFA supply, 
the compensatory hyperinsulinemia stimulates fatty acid 
synthesis and inhibits fatty acid catabolism in the hepa-
tocytes. When fatty acid input overcomes the capacity 
of  β-oxidation, accumulating acyl-CoA is drained by tri-
glyceride synthesis, which leads to steatosis in the liver 
(Figure 2A).
Accumulation of  fatty acids or fatty acyl-CoAs, how-
ever, may be more harmful to hepatocytes than deposi-
tion of  triglycerides. It has been demonstrated in HepG2 
and Huh7 human liver cell lines that lipotoxic effect of  
the saturated stearate is initiated by interruption of  tria-
cylglycerol synthesis. Retained capacity to synthesize and 
accumulate triglycerides in the presence of  unsaturated 
oleate, in fact, turned out to be protective[18]. 
TOXICITY OF SATURATED FATTY ACIDS 
AND TRANS FATTY ACIDS 
The typical dietary pattern of  western populations leads 
to high intake of  saturated fatty acids (SFAs) derived 
from animal sources. Their metabolic and health effects 
are similar to those of  trans fatty acids (TFAs), i.e., un-
saturated fatty acids containing at least one non-conju-
gated double bond in the trans configuration. TFAs are 
also found in foods of  natural origin because ruminant 
animals obtain these lipids from bacterial hydrogenation 
of  unsaturated fatty acids in the rumen[19]. In addition, 
TFAs are also formed during the industrial production 
of  certain foods, and major food sources of  dietary TFA 
in the United States. population were found to be cakes, 
cookies, pies and pastries[20]. The proinflammatory status 
favored by both SFAs and TFAs plays an important role 
in several diseases[21].
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Figure 2  Fatty acid toxicity in the liver. A: Balanced (over) supply of satu-
rated and unsaturated fatty acids allows the hepatocyte to enhance triglyceride 
synthesis and deposition. Storage of excess fatty acids prevents superfluous 
fatty acid oxidation and thereby protects against oxidative stress; B: Dispro-
portionate abundance of saturated fatty acids might not be compensated for 
by fatty acid desaturation (dashed lines). Hindrance of protective fat synthesis 
favors fatty acid oxidation and leads to excessive ROS generation; The emerg-
ing oxidative stress and the increased saturation of membrane lipids trigger 
the endoplasmic reticulum (ER) stress response, which contributes to insulin 
resistance and further enhances cell death (dotted lines).
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The greater hepatotoxicity of  saturated vs unsatu-
rated fatty acids has been demonstrated in several stud-
ies[18,22-25]. Moreover, the unsaturated fatty acids often 
prove to be protective against SFA-induced toxici-
ty[18,24]. Interruption of  triglyceride synthesis, apparently 
because of  the formation of  a pool of  oversaturated 
intermediates, seems to be a key event in SFA-induced 
lipotoxicity. Accumulation of  stearoyl-CoA and a de-
creased capacity of  triglyceride production have been 
found in HepG2 and Huh7 human hepatoma cells 
exposed to stearate[18]. In accordance with its central 
role in converting SFAs to monounsaturated fatty acids 
(MUFAs), SCD1 proved to be protective against SFA-
induced hepatocyte lipoapoptosis (Figure 2B). Studies 
on SCD1 knockout mice lead to the conclusion that 
prevention of  steatohepatitis involves partitioning 
excess SFAs into MUFAs by hepatic SCD1[26]. Hepa-
tocytes of  Ncb5or knockout mice have an increased 
sensitivity to SFA-induced damage, which can be at 
least partly attributed to a lower SCD-specific activity 
in these cells[27]. This observation strongly supports the 
hypothesized functional link between SCD1 and Nc-
b5or[8]. Some natural human mutations of  NCB5OR 
have been reported to remarkably decrease the level of  
active enzyme due to enhanced proteasomal degrada-
tion[28]; therefore, the potential role of  this gene in hu-
man pathology deserves further investigation.
Controversial data have been published regarding the 
control of  autophagy by unsaturated and saturated fatty 
acids in primary hepatocytes and hepatoma cells[29,30]. Al-
though oleic acid has been found to induce autophagy-
mediated apoptosis in mild but not in severe steatosis in 
HepG2 cells[31], it seems plausible that fatty acid-induced 
autophagy generally plays a pro-survival role in lipotoxic-
ity[29,30,32]. However, hindrance of  the autophagic flux by 
oxidative stress and/or advanced apoptosis[29,32] is more 
likely to occur in SFA-induced lipotoxicity. Therefore, 
the greater toxicity of  saturated vs unsaturated fatty acids 
might be also attributed to differential regulation of  au-
tophagy. 
The health risk raised by the increasing ingestion of  
TFAs has recently got into the focus of  scientific inter-
est. The relationship between dietary fat induced obesity 
and TFAs is not unequivocally elucidated. Nevertheless, 
dietary intake of  high TFAs increases liver weight and 
hepatic triglyceride content, and causes deleterious al-
terations in serum cholesterol levels in rats[33]. TFAs have 
been shown to be a primary factor responsible for the 
development of  NAFLD in an animal model of  Ameri-
can lifestyle induced obesity syndrome either with[34] or 
without inclusion of  high fructose corn syrup[35,36] in the 
diet. Increased hepatic lipid peroxidation as an indicator 
of  oxidative stress has also been demonstrated in the 
livers of  high TFA-fed rats, and it might underlie the de-
velopment of  NAFLD[37]. Long term ingestion of  TFAs 
has been shown to increase liver triglycerides due to en-
hanced activity and expression of  lipogenic enzymes and 
elevated expression of  sterol regulatory element-binding 
protein SREBP-1a in mice. However these effects largely 
depend on the dietary fatty acid composition[38]. The 
extent and severity of  health injuries caused by TFAs as 
well as the mechanisms of  TFA-induced hepatotoxicity 
remain to be clarified. 
LIPOTOXIC OXIDATIVE STRESS
Several observations suggest the role of  increased reac-
tive oxygen species (ROS) generation in hepatic lipotox-
icity. Growing oxidative challenge is well demonstrated 
by increased serum levels of  ox-LDL and higher serum 
lipid peroxidation in nonalcoholic steatohepatitis[39]. 
Palmitate-induced oxidative stress has been reported 
to contribute to insulin resistance in H4IIEC3 rat he-
patocytes[40]. Fatty acid accumulation stimulates ROS 
generation in the liver presumably due to enhanced 
β-oxidation and to the consequent electron overflow 
in the mitochondrial electron transfer chain[41] (Figure 
2B). However, a decrease in mitochondrial quinone pool 
and a related inhibition of  mitochondrial oxidative me-
tabolism were also suggested to underlie the increased 
mitochondrial ROS production in high fat diet[42]. Mi-
tochondrial depolarization, cytochrome c release, and 
increased ROS production were detected in HepG2 and 
McNtcp.24 liver cells exposed to saturated FFAs, and 
the role of  lysosomal disruption was also suggested[43]. 
Increased expression[44] and activity[45,46] of  cytochrome 
P450 2E1 (CYP2E1) monooxygenase likely contributes 
to the oxidative stress in lipotoxicity. CYP2E1 is an in-
tegral membrane protein of  the ER and a significant 
source of  oxidative intermediates including free radicals. 
It is involved in the biotransformation of  several endo/
xenobiotics, and it carries out omega hydroxylation of  
fatty acids. CYP2E1 activity was shown to positively 
correlate with body mass index and with the degree of  
steatosis[47]. The role of  omega hydroxylating CYP4A 
isoenzymes was also suggested in animal models of  non-
alcoholic steatohepatitis[48]. CYP4A enzymes are under 
control of  peroxisome proliferator activated receptors, 
which also induce peroxisomal fatty acid beta oxidation, 
another prominent ROS generating pathway[49]. Besides 
the enhancement of  oxidative fatty acid metabolism, pal-
mitate-mediated up-regulation of  direct ROS production 
by NADPH oxidase 3 has been also revealed recently in 
db/db mice and HepG2 cells[50].
Excessive ROS production is directly deleterious 
by injuring DNA, proteins and lipids. It also favors cell 
death through activation of  certain stress-sensitive sig-
naling pathways, such as nuclear factor κB, p38MAPK, 
and c-Jun N-terminal kinase (JNK)[51,52]. In addition, 
a general cellular oxidative stress inevitably affects the 
intricate redox homeostasis in the ER lumen[53-55]. The 
controlled maintenance of  an oxidized thiol-disulfide 
redox system in this compartment is the prerequisite of  
appropriate protein maturation[56]. On the other hand, 
the sufficiently reduced pyridine nucleotide pool in the 
ER lumen provides a metabolic basis for prereceptor 
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glucocorticoid hormone activation[57,58]. 
LIPOTOXIC ER STRESS
Protein processing, one of  the major functions of  the 
ER[56,59], is necessarily affected by any severe dysfunction 
of  the organelle, i.e., the ER stress[60]. Lowered protein 
folding capacity of  the ER renders it unable to keep pace 
with protein load. Accumulation of  immature proteins 
in the ER lumen triggers a complex primarily adaptive 
signaling network called the unfolded protein response 
(UPR) in order to restore ER homeostasis. Unfolded 
proteins recruit increasing amounts of  BiP, ER chaper-
one, which is thus detached from the luminal domains 
of  three transmembrane ER stress sensor proteins: 
RNA-dependent protein kinase-like ER kinase (PERK), 
inositol-requiring enzyme 1 (IRE1) and activating tran-
scription factor 6 (ATF6). They initiate the three main 
branches of  the UPR collectively inducing attenuation 
of  protein synthesis, expression of  ER chaperones, and 
degradation of  misfolded proteins[61].
Phosphorylation of  eukaryotic initiation factor 
eIF2α by PERK lowers the ER protein load by attenuat-
ing general translation, and also enhances the synthesis 
of  ATF4 transcription factor. IRE1-mediated specific 
mRNA splicing allows the synthesis of  X-box-binding 
protein 1 (XBP1) transcription factor, which enhances 
the ATF6-dependent adaptive transcriptional altera-
tions (e.g., induction of  ER chaperones). When the UPR 
fails to restore the ER functions, the ER-derived death 
signals may take effect. Apoptosis is stimulated mostly 
by induction of  CCAAT/enhancer binding protein ho-
mologous protein (CHOP) and activation of  JNK. It 
should be noted that JNK activation is also triggered by 
the oxidative stress in lipotoxicity[50]. In addition to its 
pro-apoptotic activity, JNK also interferes with insulin 
signaling by phosphorylating insulin receptor substrate-1 
(IRS-1) at serine (307)[62], which represents a key link be-
tween ER-stress and insulin resistance.
ER stress contributes to the pathology of  several 
liver diseases associated with steatosis. Activation of  the 
UPR is involved in fatty liver disease either alcoholic or 
non-alcoholic as well as viral hepatitis. Enhanced apop-
tosis of  liver cells in these diseases may be at least partly 
due to unresolved ER stress[63]. Mounting evidence sup-
port the involvement of  ER dysfunctions in the toxicity 
of  fatty acids, especially long chain, saturated ones. The 
programmed cell death, at least partly due to ER stress, 
caused by fatty acids is referred to as lipoapoptosis. 
The role of  PERK/ATF4/CHOP signaling pathway 
has been demonstrated in saturated fatty acid-induced 
ER stress and lipoapoptosis in L02 and HepG2 human 
liver cell lines[64]. Elevated exogenous pamitate has been 
shown to disrupt ER homeostasis by reducing the ex-
pression of  Bip in HepG2 cells. Overexpression of  Bip 
attenuated ER stress, reduced CHOP expression and 
protected the cells from palmitate-induced apoptosis[22]. 
Lipotoxic derangement of  ER functions is likely due to 
the above mentioned oxidative stress, disturbed calcium 
homeostasis and altered membrane saturation. Mem-
brane bound and luminal oxidase enzymes maintain a 
thiol oxidizing environment in the ER, a prerequisite of  
oxidative folding[65]. It is therefore not surprising that the 
protein processing machinery of  the organelle is sensi-
tive to any disturbance of  the redox and antioxidant 
status of  the cell[66]. Inhibition of  fatty acid oxidation 
has been shown to protect hepatocytes from ER stress, 
and this was accompanied by an increased cellular redox 
potential as judged by an elevated ratio of  oxidized to re-
duced glutathione and enhanced oxidative folding in the 
ER[67]. Saturated, long chain fatty acids have been shown 
to reduce thapsigargin-sensitive ER calcium stores and 
increase biochemical markers of  ER stress in H4IIE 
liver cells and primary hepatocytes[24]. Palmitate- but not 
linoleate-induced ER stress was prevented by depletion 
of  intracellular calcium flux in the same cell line[68].
It has been demonstrated that insufficient desaturase 
activity (SCD1 knockdown) or decreased incorporation 
of  unsaturated fatty acids in membrane phospholipids 
(LPCAT3 knockdown) can synergistically induce the 
UPR. The effect is likely due to a decrease in membrane 
phospholipids unsaturation as it is further enhanced by 
saturated while it is rescued by unsaturated fatty acids[69] 
(Figure 2B). Recent findings suggest that ER lipid per-
turbation can trigger the UPR directly and independently 
of  luminal accumulation of  unfolded proteins. The 
mechanisms through which the UPR is activated by ac-
cumulating unfolded proteins and membrane lipid satu-
ration turned out to be different as the latter does not 
involve large protein cluster formation in the ER mem-
brane[70]. Two of  the ER stress receptors, IRE1α and 
PERK have been revealed to respond to increased lipid 
saturation. Their lipid sensitivity was retained when the 
luminal unfolded protein sensing domains were removed 
and was associated to their transmembrane domains[71]. 
This novel mechanism is in accordance with the greater 
toxicity of  saturated vs unsaturated fatty acids as well 
as with the protective effect of  unsaturated fatty acids 
against saturated fatty acid induced toxicity[18,22-25]. 
The thapsigargin- and tunicamycin-induced UPR was 
found to increase the expression of  sterol regulatory 
element-binding protein (SREBP-1c) transcription fac-
tor in HepG2 cells, through the cap-independent trans-
lation mediated by an internal ribosome entry site[72]. 
Thapsigargin-induced SREBP-1c activation and the 
consequent stimulation of  fatty acid synthesis were also 
confirmed in the normal human L02 cell line[73]. This ef-
fect might create a positive feed back loop and further 
aggravate the metabolic disorder in lipotoxic ER stress. 
On the other hand, several genes related to lipoprotein 
secretion are controlled by IRE1α, and hence induction 
of  the UPR upon membrane lipid perturbation might 
contribute to the prevention of  hepatic steatosis[74]. 
Interestingly, mice with hepatocyte-specific IRE1α dele-
tion without ER stress display modest hepatosteatosis, 
and this is aggravated after induction of  ER stress[74]. 
Therefore, disturbed lipid metabolism can lead to ER 
stress and trigger the UPR, and the ER stress-dependent 
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alteration in lipid homeostasis might underlie the hepatic 
steatosis.  
CONCLUSION
The unhealthy combination of  modern diet and lifestyle 
often leads to nutrient surplus and a consequent fat 
deposition in various non-adipose tissues including the 
liver. This hepatosteatosis has long been considered as 
the fundamental cause of  hepatic injuries characterizing 
both alcoholic and non-alcoholic fatty liver diseases, i.e. 
oxidative and ER stress, cell death, inflammation and 
fibrosis. In light of  recent studies, however, fat accumu-
lation is considered rather protective as the hepatocyte 
damage is mostly caused by fatty acyl-CoA (Figure 1A). 
Enhanced triglyceride synthesis decreases the oxidative 
challenge by lowering fatty acid oxidation. The higher 
toxicity of  SFAs vs unsaturated fatty acids seems to be 
at least partly due to an increased tendency of  the SFAs 
to accumulate because of  a limited capacity of  the liver 
cells to insert them into triglycerides (Figure 2B). SFA-
induced toxicity is indeed enhanced by insufficient activ-
ity of  the enzymes involved in fatty acid desaturation 
and triglyceride synthesis while attenuated by simultane-
ous administration of  unsaturated fatty acids. Moreover, 
growing evidence indicates that increased saturation 
of  phospholipid membranes can trigger the ER stress 
response though a unique mechanism. The activated sig-
naling pathways lead to insulin resistance and hepatocyte 
apoptosis, significantly contributing to aggravation of  
the metabolic derangements and liver injuries caused by 
SFAs (Figure 2B).
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